IP Verse

Glaxosmithkline Biologicals Sa V. Pfizer Inc. - 1:24-cv-00512

Explore the details of the Glaxosmithkline Biologicals Sa V. Pfizer Inc. case under case number 1:24-cv-00512 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00512
Filing Date
Apr 25, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
BioNTech Manufacturing GmbH -
GlaxoSmithKline Biologicals SA -
Pfizer Inc. -
Pharmacia & Upjohn Co. LLC -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Apr 25, 2024Summonses Issued as to BioNTech US Inc., Pfizer Inc., and Pharmacia & Upjohn Co. LLC on 4/25/2024. (Attachments: # 1 Summons Issued Pfizer Inc., # 2 Summons Issued Pharmacia & Upjohn Company LLC)(jfm) (Entered: 04/25/2024)Attachment
Apr 9, 2025NOTICE of Supplemental Authority by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC re 42 Answering Brief in Opposition, 43 Reply Brief, (Attachments: # 1 Exhibit A)(Farnan, Kelly) (Entered: 04/09/2025)Attachment
Sep 20, 2024OPENING BRIEF in Support re 34 MOTION to Dismiss for Failure to State a Claim Partial Motion to Dismiss Counterclaims and Strike Affirmative Defenses of Patent Misuse and Prosecution Laches filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC.Answering Brief/Response due date per Local Rules is 10/4/2024. (Attachments: # 1 Exhibit 1)(Farnan, Kelly) (Entered: 09/20/2024)Attachment
Apr 10, 2025NOTICE of Subpoena Duces Tecum to Novartis Services Inc. by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC (Attachments: # 1 Exhibit 1)(Metzler, Sara) (Entered: 04/10/2025)Attachment
Aug 14, 2024First AMENDED COMPLAINT for Patent Infringement against BioNTech Manufacturing GmbH, BioNTech SE, BioNTech US Inc., Pfizer Inc., Pharmacia & Upjohn Co. LLC- filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. (Attachments: # 1 Exhibit 1-7, # 2 Exhibit 8-26, # 3 Exhibit 27-68, # 4 Exhibit 69-82, # 5 Exhibit 83-91, # 6 Exhibit 92-103, # 7 Exhibit 104-114, # 8 Exhibit 115-120)(Farnan, Kelly) (Entered: 08/14/2024)Attachment
Aug 14, 2024First AMENDED COMPLAINT for Patent Infringement against BioNTech Manufacturing GmbH, BioNTech SE, BioNTech US Inc., Pfizer Inc., Pharmacia & Upjohn Co. LLC- filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. (Attachments: # 1 Exhibit 1-7, # 2 Exhibit 8-26, # 3 Exhibit 27-68, # 4 Exhibit 69-82, # 5 Exhibit 83-91, # 6 Exhibit 92-103, # 7 Exhibit 104-114, # 8 Exhibit 115-120)(Farnan, Kelly) (Entered: 08/14/2024)Attachment
Aug 14, 2024First AMENDED COMPLAINT for Patent Infringement against BioNTech Manufacturing GmbH, BioNTech SE, BioNTech US Inc., Pfizer Inc., Pharmacia & Upjohn Co. LLC- filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. (Attachments: # 1 Exhibit 1-7, # 2 Exhibit 8-26, # 3 Exhibit 27-68, # 4 Exhibit 69-82, # 5 Exhibit 83-91, # 6 Exhibit 92-103, # 7 Exhibit 104-114, # 8 Exhibit 115-120)(Farnan, Kelly) (Entered: 08/14/2024)Attachment
Aug 14, 2024First AMENDED COMPLAINT for Patent Infringement against BioNTech Manufacturing GmbH, BioNTech SE, BioNTech US Inc., Pfizer Inc., Pharmacia & Upjohn Co. LLC- filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. (Attachments: # 1 Exhibit 1-7, # 2 Exhibit 8-26, # 3 Exhibit 27-68, # 4 Exhibit 69-82, # 5 Exhibit 83-91, # 6 Exhibit 92-103, # 7 Exhibit 104-114, # 8 Exhibit 115-120)(Farnan, Kelly) (Entered: 08/14/2024)Attachment
Aug 14, 2024First AMENDED COMPLAINT for Patent Infringement against BioNTech Manufacturing GmbH, BioNTech SE, BioNTech US Inc., Pfizer Inc., Pharmacia & Upjohn Co. LLC- filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. (Attachments: # 1 Exhibit 1-7, # 2 Exhibit 8-26, # 3 Exhibit 27-68, # 4 Exhibit 69-82, # 5 Exhibit 83-91, # 6 Exhibit 92-103, # 7 Exhibit 104-114, # 8 Exhibit 115-120)(Farnan, Kelly) (Entered: 08/14/2024)Attachment
Aug 14, 2024First AMENDED COMPLAINT for Patent Infringement against BioNTech Manufacturing GmbH, BioNTech SE, BioNTech US Inc., Pfizer Inc., Pharmacia & Upjohn Co. LLC- filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. (Attachments: # 1 Exhibit 1-7, # 2 Exhibit 8-26, # 3 Exhibit 27-68, # 4 Exhibit 69-82, # 5 Exhibit 83-91, # 6 Exhibit 92-103, # 7 Exhibit 104-114, # 8 Exhibit 115-120)(Farnan, Kelly) (Entered: 08/14/2024)Attachment
Aug 14, 2024First AMENDED COMPLAINT for Patent Infringement against BioNTech Manufacturing GmbH, BioNTech SE, BioNTech US Inc., Pfizer Inc., Pharmacia & Upjohn Co. LLC- filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. (Attachments: # 1 Exhibit 1-7, # 2 Exhibit 8-26, # 3 Exhibit 27-68, # 4 Exhibit 69-82, # 5 Exhibit 83-91, # 6 Exhibit 92-103, # 7 Exhibit 104-114, # 8 Exhibit 115-120)(Farnan, Kelly) (Entered: 08/14/2024)Attachment
Aug 14, 2024First AMENDED COMPLAINT for Patent Infringement against BioNTech Manufacturing GmbH, BioNTech SE, BioNTech US Inc., Pfizer Inc., Pharmacia & Upjohn Co. LLC- filed by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. (Attachments: # 1 Exhibit 1-7, # 2 Exhibit 8-26, # 3 Exhibit 27-68, # 4 Exhibit 69-82, # 5 Exhibit 83-91, # 6 Exhibit 92-103, # 7 Exhibit 104-114, # 8 Exhibit 115-120)(Farnan, Kelly) (Entered: 08/14/2024)Attachment
May 5, 2025Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Discovery Dispute - re 68 Order,,,. (Attachments: # 1 Exhibits 1-2)(Tigan, Jeremy) (Entered: 05/05/2025)Attachment
Apr 15, 2025STATEMENT re 59 Notice (Other) -- Defendants' Response to Notice of Supplemental Authority -- by BioNTech Manufacturing GmbH, BioNTech SE, BioNTech US Inc., Pfizer Inc., Pharmacia & Upjohn Co. LLC. (Attachments: # 1 Exhibit 1)(Tigan, Jeremy) (Entered: 04/15/2025)Attachment
Jun 13, 2025PROPOSED ORDER Stipulated Protective Order re 75 Memorandum and Order by GlaxoSmithKline Biologicals SA, GlaxoSmithKline LLC. (Attachments: # 1 Cover Letter to The Honorable Gregory B. Williams)(Farnan, Kelly) (Entered: 06/13/2025)Attachment
Mar 11, 2025Letter to The Honorable Gregory B. Williams from Kelly E. Farnan regarding scheduling order. (Attachments: # 1 Text of Proposed Order)(Farnan, Kelly) (Entered: 03/11/2025)Attachment
May 5, 2025Letter to The Honorable Gregory B. Williams from Kelly E. Farnan regarding Protective Order Dispute - re 68 Order,,,. (Attachments: # 1 Exhibit A-C)(Farnan, Kelly) (Entered: 05/05/2025)Attachment
Jul 31, 2025NOTICE of Subpoenas to Cayman Chemical Co. by BioNTech Manufacturing GmbH, BioNTech SE, BioNTech US Inc., Pfizer Inc., Pharmacia & Upjohn Co. LLC (Tigan, Jeremy) (Entered: 07/31/2025)PACER Document
Jul 31, 2025NOTICE OF SERVICE of (1) Pfizer's Supplemental Responses and Objections to Plaintiffs' Interrogatories (Nos. 2 and 9-10); and (2) BioNTech's Supplemental Responses and Objections to Plaintiffs' Interrogatories (Nos. 2 and 9-10) filed by BioNTech Manufacturing GmbH, BioNTech SE, BioNTech US Inc., Pfizer Inc., Pharmacia & Upjohn Co. LLC.(Tigan, Jeremy) (Entered: 07/31/2025)PACER Document